| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/10/2000 | CN1052240C Method for preparing inhibitor of retroinfection viral protease |
| 05/10/2000 | CA2289314A1 Chemotactic peptide antagonists for imaging sites of inflammation |
| 05/09/2000 | US6060462 Electrophilic peptide analogs as inhibitors of trypsin-like enzymes |
| 05/09/2000 | US6060451 Thrombin inhibitors based on the amino acid sequence of hirudin |
| 05/09/2000 | US6060257 Tumor rejection antigens presented by HLA-B44 molecules, and uses thereof |
| 05/09/2000 | US6060065 Compositions for inhibition of membrane fusion-associated events, including influenza virus transmission |
| 05/09/2000 | US6060056 Composition for inducing humoral anergy to an immunogen comprising a T cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic valency platform molecule |
| 05/09/2000 | US6060051 Strain of bacillus for controlling plant diseases and corn rootworm |
| 05/09/2000 | US6060037 Conjugated compounds which comprise an st receptor binding moiety and a radiostable active moiety |
| 05/09/2000 | CA2153584C Cytokine restraining agents |
| 05/09/2000 | CA2100586C Htlv-i and htlv-ii peptide antigens and methods |
| 05/09/2000 | CA2057860C Immunoactive peptides and antibodies and their use in anti-allergy treatment |
| 05/09/2000 | CA1340988C Therapeutic peptides |
| 05/09/2000 | CA1340985C Peptide derivatives |
| 05/04/2000 | WO2000024913A2 Mn gene and protein |
| 05/04/2000 | WO2000024884A2 Antigen-binding proteins comprising a linker which confers restricted conformational flexibility |
| 05/04/2000 | WO2000024764A1 Lhrh analogues for the treatment of osteoporosis |
| 05/04/2000 | WO2000024694A1 Photochemical process for making 1-deoxy-2-keto derivatives |
| 05/04/2000 | WO2000002917A3 Compounds and methods for modulating cadherin-mediated functions |
| 05/04/2000 | WO1999064038A9 Novel analgesic agents |
| 05/04/2000 | WO1999064031A9 β2-ADRENERGIC RECEPTOR AGONISTS |
| 05/04/2000 | CA2763066A1 Mn gene and protein |
| 05/04/2000 | CA2249648A1 Mammalian subtilisin/kexin isozyme ski-1: a proprotein convertase with a unique cleavage specificity |
| 05/03/2000 | EP0996709A1 INHIBITORS OF CELLULOLYTIC, XYLANOLYTIC AND $g(b)-GLUCANOLYTIC ENZYMES |
| 05/03/2000 | EP0996636A1 The ha-1 antigen |
| 05/03/2000 | EP0996634A1 Crystal of sm3 antibody (fragment) and recognizing epitope, its preparation, encoded data storage medium containing its coordinates and its diagnostical or medical use |
| 05/03/2000 | EP0996458A1 Sandramycin analogs |
| 05/03/2000 | EP0996457A1 Fsh-releasing peptides |
| 05/03/2000 | EP0996455A1 $g(a)-O-LINKED GLYCOCONJUGATES WITH CLUSTERED (2,6)-ST EPITOPES, METHODS OF PREPARATION AND USES THEREOF |
| 05/03/2000 | EP0776334A4 Stable analogs of bioactive peptides containing disulfide linkages |
| 05/03/2000 | EP0383803B1 Oligonucleotide-polyamide conjugates |
| 05/03/2000 | CN1052011C Vaccin peptide of blood fluke |
| 05/02/2000 | US6057294 Peptide |
| 05/02/2000 | US6057291 Antimicrobial cationic peptides |
| 05/02/2000 | US6057142 Human chitinase, its recombinant production, its use for decomposing chitin, its use in therapy or prophylaxis against infection diseases |
| 05/02/2000 | US6057132 Nucleotide sequences encoding apoptosis associated Bbk protein |
| 05/02/2000 | CA2022740C Cyclic neurokinin a antagonists |
| 05/02/2000 | CA2020838C Hemoregulatory peptides |
| 05/02/2000 | CA2011878C Immunogenic regions on the e7 protein of human papillomavirus type 16 |
| 04/27/2000 | WO2000023464A2 Zinc finger binding domains for gnn |
| 04/27/2000 | WO2000023463A2 Fluorescent dye binding peptides |
| 04/27/2000 | WO2000023092A1 Contulakin-g, analogs thereof and uses therefor |
| 04/27/2000 | WO1999063933A9 Multivalent agonists, partial agonists and antagonists of the gaba receptors |
| 04/27/2000 | CA2622786A1 Neovascular-specific peptides |
| 04/26/2000 | EP0995761A2 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders |
| 04/26/2000 | EP0995758A1 Physiologically active polyoxypeptin and deoxypolyoxypeptin and anticancer drugs containing the same |
| 04/26/2000 | EP0994898A1 Integrin binding peptide and use thereof |
| 04/26/2000 | EP0994724A1 Methods and compositions for impairing multiplication of hiv-1 |
| 04/26/2000 | EP0873417A4 Compositions for the detection of proteases in biological samples and methods of use thereof |
| 04/26/2000 | EP0832108B1 Process for recovering water-insoluble compounds from a fermentation broth |
| 04/26/2000 | EP0771209A4 Novel peptides |
| 04/26/2000 | EP0656945B1 Stress protein epitopes |
| 04/26/2000 | EP0656013B1 Peptides, analogues and mixtures thereof for detecting and eliciting antibodies to the e1 and e2 protein of rubella virus |
| 04/26/2000 | CN1251530A Use of substaces having oxytocin activity for preparation of medicaments for wound healing |
| 04/25/2000 | US6054637 Signal sequences for vacuolar sorting |
| 04/25/2000 | US6054565 Nucleic Acids of HIV-2, Diagnostic Test Kit and Method using Nucleic Acid Probes of HIV-2 |
| 04/25/2000 | US6054557 Fluorescent peptides |
| 04/25/2000 | US6054436 Regulated apoptosis |
| 04/25/2000 | US6054303 Cyclosporins conjugated at an alanine nitrogen atom to an immunogenic carrier, a ligand, a small organic compound or a label through a linker of alkylene oxide chain or carbonyloxybenzyl group including 1-3 carboxamide groups |
| 04/25/2000 | US6054265 Screening assays for compounds that inhibit membrane fusion-associated events |
| 04/25/2000 | US6054119 Preparation used in dental care |
| 04/25/2000 | CA2155728C Regulated transcription of targeted genes and other biological events |
| 04/20/2000 | WO2000022129A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 04/20/2000 | WO2000022000A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 04/20/2000 | WO2000021987A2 A method of identifying modulators of cell surface membrane receptors useful in the treatment of disease |
| 04/20/2000 | WO2000021982A1 A process for the preparation of a thrombus imaging agent |
| 04/20/2000 | WO2000021981A2 TNFα BINDING PEPTIDES AND THEIR UTILIZATION FOR DETECTING, DEACTIVATING AND/OR REMOVING TNFα FROM BIOLOGICAL FLUIDS |
| 04/20/2000 | WO2000021567A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 04/20/2000 | WO1999065712A3 Glycosulfopeptides and methods of synthesis and use thereof |
| 04/20/2000 | WO1999064050A9 Novel potassium channel drugs and their uses |
| 04/20/2000 | WO1999064000A9 Novel therapeutic agents that modulate neurokinin receptors |
| 04/20/2000 | CA2346066A1 Ionic molecular conjugates of n-acylated derivatives of poly(2-amino-2-deoxy-d-glucose) and polypeptides |
| 04/20/2000 | CA2343356A1 Methods for the production of antibodies to specific regions of cyclosporine and cyclosporine metabolites |
| 04/20/2000 | CA2342314A1 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 04/20/2000 | CA2341975A1 A process for the preparation of a thrombus imaging agent |
| 04/19/2000 | EP0994121A2 Branched peptides in assays for antibodies |
| 04/19/2000 | EP0993307A2 TECHNETIUM-99m LABELED CHELATOR INCORPORATED CYCLIC PEPTIDES |
| 04/19/2000 | EP0993303A1 Substances in order to achieve preference and create acceptance |
| 04/19/2000 | EP0222835B2 Oral vaccines |
| 04/19/2000 | CN1251042A Identification of broadly reactive DR restricted epitopes |
| 04/19/2000 | CN1251041A Fine tuned progegrins |
| 04/19/2000 | CN1250669A Ion composite type water-soluble pharmaceutical compositions, and use thereof |
| 04/18/2000 | US6051559 Cloning and characterizing of genes associated with long-term memory |
| 04/18/2000 | US6051555 Administering a peptide |
| 04/18/2000 | US6051549 Heparin and sulfatide binding peptides from the type-I repeats of human thrombospondin and conjugates thereof |
| 04/18/2000 | US6051429 Peptide-enhanced cationic lipid transfections |
| 04/18/2000 | CA2019005C Antiherpes pentapeptide derivatives having a cycloalkyl substituted aspartic acid side chain |
| 04/13/2000 | WO2000020587A2 Cancer associated antigens and uses therefor |
| 04/13/2000 | WO2000020581A1 Mage-a3 peptides presented by hla class ii molecules |
| 04/13/2000 | WO2000020572A2 Tissue binding peptides, identification, production and utilization thereof |
| 04/13/2000 | WO2000020457A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 04/13/2000 | WO2000020445A2 Tumor antigens and ctl clones isolated by a novel procedure |
| 04/13/2000 | WO2000020444A1 Novel peptides |
| 04/13/2000 | WO2000020443A1 Novel peptides |
| 04/13/2000 | WO2000020441A2 Cyclic peptides as antifungal agents |
| 04/13/2000 | WO2000002916A3 PEPTIDE COMPOSITIONS MIMICKING TGF-β ACTIVITY |
| 04/13/2000 | WO2000000509A3 Peptides for inhibiting hpv e7 proteins |
| 04/13/2000 | CA2345477A1 Peptides related to an igf-ii-r epitope, polynucleotides encoding the peptides, and their use in immunomodulation |
| 04/13/2000 | CA2345214A1 Tissue binding peptides, identification, production and utilization thereof |
| 04/13/2000 | CA2344995A1 Cancer associated antigens and uses therefor |